by Pete Celano | Sep 6, 2025 | Uncategorized
The May 2025 article “Prediction of Hypertension Risk in Patients with Fatty Liver Disease Using the Triglyceride-Glucose-Body Mass Index” shows the link between Hypertension (HTN) patients and Fatty Liver Disease (FLD).Key quote: “FLD and HTN...
by Pete Celano | Aug 30, 2025 | Uncategorized
Two words: Biopsy Avoidance. Here’s a summary of the Gastroenterology & Endoscopy News article “In Lieu of Biopsy: A Review of Noninvasive Liver Disease Assessments” (posted August 28, 2025): Overview Purpose: The article reviews noninvasive liver disease...
by Pete Celano | Aug 28, 2025 | Uncategorized
The Hepatoscope® from E-Scopics Big news here from 08/27/2025: “FDA accepts proposal for reasonably likely surrogate endpoint for ‘MASH’ all-cause mortality or liver-related events.”The key paragraph:”The proposed biomarker offers a non-invasive...
by Pete Celano | Aug 27, 2025 | Uncategorized
Here’s a concise summary of the article titled “FIB-4-based Referral Pathways Have Suboptimal Accuracy to identify Increased Liver Stiffness and Incident Advanced Liver Disease” from July of 2025, as published in Clinical Gastroenterology and Hepatology.The...
by Pete Celano | Aug 22, 2025 | Uncategorized
From August 7, 2025MINNEAPOLIS–(BUSINESS WIRE)–HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced a management-led majority stake acquisition by a syndicate of globally recognized private...
